Clinical Trials Begin for Testing Safety of HIV Prevention Gel

Sep 05, 2006 at 02:41 pm by steve


Researchers at the University of Alabama at Birmingham (UAB) are beginning a clinical trial to assess the safety of a vaginal gel containing the HIV drug tenofovir, designed to protect against HIV and sexually transmitted infections. They are seeking healthy woman between the ages of 19-50 to participate in the clinical trial. Those interested in participating should call 205-996-6126 for more information. Tenofovir is an anti-AIDS drug that stops HIV from invading cells that have not yet been infected with the virus. It already has been tested in thousands of HIV-infected persons and it is being used in an oral form for HIV treatment. Animal studies have shown that tenofovir gel can prevent transmission of a virus similar to HIV, but it is not yet known whether it has the same affect in humans.



Cover image of the January 2025 issue of Birmingham Medical News

January 2025

Jan 10, 2025 at 11:39 am by kbarrettalley

Your January 2025 Issue of Birmingham Medical News is Here!